E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/5/2006 in the Prospect News Biotech Daily.

St. Jude kept at peer perform by Bear Stearns

St. Jude Medical, Inc. was maintained at a peer perform rating by Bear Stearns analyst Rick Wise on disappointing first-quarter 2006 preliminary sales results of $784 million, roughly 5% below the analyst's estimate of $825 million and consensus estimate $828 million. Pre-announced first-quarter 2006 post-option earnings per share were $0.35-0.36, compared to Bear Stearns' estimate of $0.38, and consensus of $0.39. Shares of the St. Paul, Minn., medical device company were down $5.05, or 12.23%, at $36.25 on volume of 51,659,400 shares versus the three-month running average of 2,827,970 shares. (NYSE: STJ)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.